MedTrace Logo

Bipap Automatic Servo Ventilation (autoSV) Advanced in Central Apnea Patients

NCT01199042 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2016-04-28

Study results available
· View outcomes & findings →

Summary

Pilot study testing the Bipap autoSV Advanced Algorithm during full night, in-lab polysomnography (PSG) and 3 months at home on patients with Central Sleep Apnea, Hunter Cheyne Stokes Respiration, or Complex Sleep Apnea.

Conditions

  • Cheyne-Stokes Respiration
  • Sleep Apnea, Central

Interventions

DEVICE

BiPAP autoSV Advanced

The sleep apnea device will be set-up in automatic mode with the settings wide open for the entire night.

Sponsors & Collaborators

  • Philips Respironics

    lead INDUSTRY

Principal Investigators

  • Shahrokh Javaheri, MD · Sleepcare Diagnostics

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2013-05-31
Completion
2013-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01199042 on ClinicalTrials.gov